Pharmafile Logo
Pharmafocus logo
Advanced Search

Press release

Showing 15 posts of 534 posts found.

New Data Showing that Transgene and NEC’s Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023

April 18, 2023
Business Services

Strasbourg, France & Tokyo, Japan, April 18, 2023, 9:00 a.m. CET/4:00 p.m. JST – Transgene (Euronext Paris: TNG), a biotech company …

News
Press release

Nouscom Presents New Positive Translational Phase 1b Data of NOUS-PEV, a Personalized Neoantigen Cancer Immunotherapy, in a Late-Breaking Abstract at AACR 2023

April 18, 2023
Business Services

BASEL, Switzerland – 18th April 2023 – Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vector immunotherapies, …

News
Press release

MED3000, Eroxon® UK Launch

April 18, 2023
Business Services

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), a pharmaceutical company developing a portfolio of innovative products based on …

News
Press release

Scancell to present ModiFY Phase 1/2 cancer vaccine clinical trial protocol and early efficacy data at the American Association for Cancer Research Annual Meeting

April 18, 2023
Business Services

Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, announces it …

News
Press release

HUTCHMED Announces NDA Acceptance in China for Fruquintinib in Second-Line Gastric Cancer

April 18, 2023
Business Services

Hong Kong, Shanghai & Florham Park, NJ — Tuesday, April 18, 2023: HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces …

News
Press release

We need more “trial” and less error – a concerted effort is required to include more people aged over 60 in clinical trials, argues longevity experts

April 18, 2023
Business Services

The Trial and error report, published today, urges regulators, pharmaceutical companies and researchers to prioritise age diversity at all stages …

News
Press release

Cantargia presents new clinical data at AACR 2023 strongly supporting nadunolimab development in pancreatic cancer

April 17, 2023
Business Services

Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today presented updated interim clinical efficacy data including subgroup analyses of first-line pancreatic cancer …

News
Press release

ClinOne Closes Series A Funding Round to Scale its Site and Participant Engagement Platform, Data Driven Insights and Interoperability

April 17, 2023
Business Services

BOSTON AND BOULDER, COLO. (PRWEB) APRIL 13, 2023 – ClinOne, the leading provider of Adaptive Experiences in clinical trials announced …

News
Press release

Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favourable Tolerability and Immunogenicity Profile

April 17, 2023
Business Services

OXFORD, United Kingdom, April 17, 2023 (GLOBE NEWSWIRE) – Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company focused on the …

News
Press release

ECCMID 2023: Shionogi Announces Real-World Evidence Demonstrating the Efficacy of Fetcroja (cefiderocol) Against Some of the Most Difficult-to-Treat Gram-Negative Bacterial Pathogens

April 17, 2023
Business Services

OSAKA, Japan, APRIL 17, 2023 – Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; …

News
Press release

PureTech Founded Entity Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMID

April 17, 2023
Business Services

CAMBRIDGE, MA, April 17, 2023 – Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based …

News
Press release

MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix)

April 17, 2023
Business Services

BOSTON and WILMINGTON, Del. – April 16, 2023 – MorphoSys U.S. Inc., a fully owned subsidiary of MorphoSys AG (FSE: …

News
Press release

MinervaX Commences First Phase 1 Clinical Study of Novel GBS Vaccine in Older Adults

April 17, 2023
Business Services

Copenhagen, Denmark, 17 April 2023 – MinervaX ApS, a privately held Danish biotechnology company developing a novel vaccine against Group …

News
Press release

MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)

April 14, 2023
Business Services

NEW YORK, April 14, 2023 — Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical …

News
Press release

UCB’s Rozanolixizumab and Zilucoplan Phase 3 Generalized Myasthenia Gravis studies published in prestigious The Lancet Neurology Journal

April 13, 2023
Business Services

Brussels (Belgium) 13 April 2023 – 07:00 AM (CET) – UCB, a global biopharmaceutical company, today announced that The Lancet Neurology …

News
Press release

Latest content

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024

Veru announces first patients enrolled in phase 2b trial for weight loss treatment

May 1, 2024

Bayer and Evotec to collaborate on precision cardiology

April 30, 2024